Merck & Co., Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRK.MX | 4578.T | AZN | PFE | JNJ | JNJ.NE | |
|---|---|---|---|---|---|---|
| Market cap | 6.91T | 6.50T | 261.25B | 170.14B | 621.22B | 849.61B |
| P/E (TTM) | 123.5 | 16.3 | 25.2 | 39.3 | 39.1 | 23.5 |
| Forward P/E | — | 23.9 | 14.9 | 10.3 | 22.2 | — |
| Price/book | 8.9 | 2.0 | 5.2 | 2.0 | 7.3 | 0.7 |
| Dividend yield | 2.24% | 1.60% | 1.90% | 5.71% | 2.07% | 2.49% |
| 1-year change | +66.97% | +51.99% | +1.17% | +21.80% | +34.43% | +40.84% |
| Today | +2.56% | −0.84% | −0.22% | −0.86% | −0.61% | −0.82% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All MRK.MX news ›Arcus Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer Data
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29
October 1, 2026 6:45 am EDT RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2026 sales and earnings conference call with institutional investors and…
Merck buys Silence and its siRNA pipeline for $1.3bn
Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in an all-cash, $1.3 billion deal that will boost its presence in RNA-focused drugs and give it a late-stage drug candidate for rare disease polycythemia vera (PV).…
Merck KGaA to buy Silence Therapeutics in all-cash deal
Merck KGaA to acquire Silence Therapeutics for $1.3B cash, a 130% premium, boosting siRNA pipeline and rare-disease focus. Merck KGaA (MKGAY) (MKGAF) has agreed to acquire Silence Therapeutics (SLN) in an all-cash deal with an enterprise…
Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send?
TradingKey Merck & Co Inc Stock (MRK) Opened Up by 3.79% on Oct 20: What Signal Does It Send? What is driving Merck & Co Inc (MRK)’s stock price up today? Merck & Co. demonstrated strong upward momentum with heightened intraday trading…
Merck Stock Forecast: MRK Bounces Off 50-Day EMA as ESMO Data and Q3 Earnings Near
My view: Bullish while Merck holds above $142.65. A close above $152 would have me looking for a retest of the $156 peak. Reuters reports that the healthcare sector hit an all-time high on Tuesday as large-cap drugmakers led a rebound from…
Merck buys biotech Silence Therapeutics for USD 1.1bn
Senior Drug Product Filling Specialist Associate Market Access Director – International Markets Senior Drug Substance Scientist Head of Medical Affairs International Markets Chef for Kvalitet og Compliance Head of Clinical Operations…
Merck KGaA agrees to buy Silence Therapeutics for roughly $1.1 billion
Merck KGaA struck a cash deal to purchase Silence Therapeutics for about $1.1 billion, valuing each American depositary share at $20. That works out to a 130% premium to Silence's prior close, and traders reacted fast: the stock more than…
Better Dividend Stock: Merck vs. Bristol Myers Squibb
Pressmaster from Pressmaster and Ri_Ya from pixabay Merck (MRK) and Bristol Myers Squibb (BMY) both raised their 2026 sales outlooks this summer. That’s good news for income investors, since a growing business keeps a dividend growing. The…
Shh! Silence Therapeutics is International Biotechnology’s ninth portfolio bid this year after Merck splashes $1.3bn
Silence Therapeutics, one of the few UK-based holdings of International Biotechnology Trust (IBT), has been acquired by German drugs giant Merck for $1.3bn cash. News of the agreed deal yesterday saw Silence’s US Nasdaq-listed shares soar…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com59
-
marketbeat.com25
-
tradingview.com12
-
themarketsdaily.com11
-
defenseworld.net10
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.